hotspot -WSS

hotspot

author：leisure time 2025-09-03 15:21:08 - browse：7

In a lab at Harvard Medical School, Professor David A. Sinclair looks into the camera from behind a row of bottles — coverage from STAT — David Sinclair in his lab at Harvard Medical School. Craig F. Walker/Globe Staff

Renowned Harvard University geneticist and longevity researcher David Sinclair recently made an astonishing assertion: Scientists had developed the first pill — well, a soft, beef-flavored chew — “proven to reverse aging” in dogs. Which miracle molecules delivered this supposed scientific breakthrough, he didn’t say. But he told his 438,000 followers on X where they could buy it: the website of Animal Bioscience, a veterinary supplement company he founded and which is headed by his brother, Nick Sinclair.

The claim in a company news release, followed by the tweet stating that the supplement was “proven to slow the effects of aging,” has sparked outrage from other scientists online, and the board of an international organization of top longevity researchers — which David Sinclair leads — will discuss the matter at its meeting this week.

Despite his enthusiasm, there is no published scientific research that has yet demonstrated the compounds in Animal Bioscience’s supplements — which have been on the market for more than a year — reverse or even slow aging in dogs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Methadone treatment changes are coming. Do they go far enough?

knowledge

WSS

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

Future doctors should be trained to promote social change

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Readout Newsletter: Bluebird, CVS, Contineum

Gene editing the human germline: What are the risks?

SCOTUS questions limit to govt efforts to fight misinformation

focus

hotspot

leisure time

Virginia high school admissions case could be legal follow

Virtual Event: March of the Biosimilars

Continuity nursing helped my family in our darkest PICU moments

H5N1 communication has been strictly for the birds

Anesthesiologist group: stop taking Ozempic before surgery

Study: Adult vaccinations pay for themselves in societal benefits

Bright Health sells Medicare Advantage business to Molina

Sanofi strikes deal with Novavax, boosting the vaccine maker

Activists slam private health insurers over coverage restrictions

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

entertainment

Medicare says breakthrough device reimbursement rule to come by summer

Argenx readies a blockbuster opportunity with drug for autoimmune disease

SCOTUS questions limit to govt efforts to fight misinformation

H5N1 communication has been strictly for the birds

Stop the failed accountable care organization experiment

Readout LOUD podcast: brain research, obesity drug sales, Novartis

leisure time

knowledge

knowledge

knowledge